Literature DB >> 3242451

Cotinine determination by immunoassays may be influenced by other nicotine metabolites.

G Schepers1, R A Walk.   

Abstract

Polyclonal rabbit anticotinine antiserum, which can be used for biomonitoring nicotine uptake by the determination of cotinine in body fluids, was checked by a competitive ELISA for its cross-reactivity with nine nicotine metabolites. The highest percentage of relative cross-reactivity (about 30%) was observed with trans-3'-hydroxycotinine, a metabolite which is known to be excreted in 3-fold higher amounts than cotinine in the urine of human smokers. Therefore, it is possible that cotinine determinations performed by immunochemical methods--especially in urine--may yield overestimated cotinine concentrations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3242451     DOI: 10.1007/BF00293630

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  16 in total

1.  Measuring problems in estimating the exposure to passive smoking using the excretion of cotinine.

Authors:  H Letzel; A Fischer-Brandies; L C Johnson; K Uberla; A Biber
Journal:  Toxicol Lett       Date:  1987-01       Impact factor: 4.372

2.  Determination of nicotine and cotinine in human serum and urine: an interlaboratory study.

Authors:  A Biber; G Scherer; I Hoepfner; F Adlkofer; W D Heller; J E Haddow; G J Knight
Journal:  Toxicol Lett       Date:  1987-01       Impact factor: 4.372

3.  Gas chromatographic determination of trans-3'-hydroxycotinine, a major metabolite of nicotine in smokers.

Authors:  G B Neurath; F G Pein
Journal:  J Chromatogr       Date:  1987-04-10

4.  Single-reagent polarisation fluoroimmunoassay for cotinine (a nicotine metabolite) in urine.

Authors:  M C Hansel; F J Rowell; J Landon; A M Sidki
Journal:  Ann Clin Biochem       Date:  1986-09       Impact factor: 2.057

5.  Interindividual variability in the metabolism and cardiovascular effects of nicotine in man.

Authors:  N L Benowitz; P Jacob; R T Jones; J Rosenberg
Journal:  J Pharmacol Exp Ther       Date:  1982-05       Impact factor: 4.030

6.  Radioimmunoassay of nicotine, cotinine, and gamma-(3-pyridyl)-gamma-oxo-N-methylbutyramide.

Authors:  J J Langone; H Van Vunakis
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

7.  Structure of hydroxycotinine, a nicotine metabolite.

Authors:  E Dagne; N Castagnoli
Journal:  J Med Chem       Date:  1972-04       Impact factor: 7.446

8.  Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine.

Authors:  J J Langone; H B Gjika; H Van Vunakis
Journal:  Biochemistry       Date:  1973-11-20       Impact factor: 3.162

9.  Nicotine and cotinine concentrations in serum and milk of nursing smokers.

Authors:  W Luck; H Nau
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

10.  Stereospecific monoclonal antibodies to nicotine and cotinine and their use in enzyme-linked immunosorbent assays.

Authors:  R J Bjercke; G Cook; N Rychlik; H B Gjika; H Van Vunakis; J J Langone
Journal:  J Immunol Methods       Date:  1986-06-24       Impact factor: 2.303

View more
  6 in total

1.  Is the hair nicotine level a more accurate biomarker of environmental tobacco smoke exposure than urine cotinine?

Authors:  W K Al-Delaimy; J Crane; A Woodward
Journal:  J Epidemiol Community Health       Date:  2002-01       Impact factor: 3.710

2.  Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity.

Authors:  Peyton Jacob; Lisa Yu; Minjiang Duan; Lita Ramos; Olivia Yturralde; Neal L Benowitz
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-12-21       Impact factor: 3.205

3.  Effects of smoking cessation with voucher-based contingency management on birth outcomes.

Authors:  Stephen T Higgins; Ira M Bernstein; Yukiko Washio; Sarah H Heil; Gary J Badger; Joan M Skelly; Tara M Higgins; Laura J Solomon
Journal:  Addiction       Date:  2010-09-15       Impact factor: 6.526

Review 4.  Chemical analyses as validators in smoking cessation programs.

Authors:  D D Gilbert
Journal:  J Behav Med       Date:  1993-06

5.  Meconium nicotine and metabolites by liquid chromatography-tandem mass spectrometry: differentiation of passive and nonexposure and correlation with neonatal outcome measures.

Authors:  Teresa R Gray; Raquel Magri; Diaa M Shakleya; Marilyn A Huestis
Journal:  Clin Chem       Date:  2008-10-09       Impact factor: 8.327

6.  Quantification of nicotine, cotinine, trans-3'-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry.

Authors:  Teresa R Gray; Diaa M Shakleya; Marilyn A Huestis
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-01-16       Impact factor: 3.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.